[Selective increase of antiviral substances in the liver in hepatitis B by recombinant chylomicrons--a useful new therapeutic approach?].
Gallwitz
B
B
I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel.
Günther
R
R
Schmidt
W E
WE
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001682:Biological Availability; D002914:Chylomicrons / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004337:Drug Carriers; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000493:pharmacokinetics
D000998:Antiviral Agents; D002914:Chylomicrons; D004337:Drug Carriers; D011994:Recombinant Proteins; D007065:Idoxuridine